138 related articles for article (PubMed ID: 30991384)
1. Incidence and Mortality of Parkinson's Disease in Estonia.
Kadastik-Eerme L; Taba N; Asser T; Taba P
Neuroepidemiology; 2019; 53(1-2):63-72. PubMed ID: 30991384
[TBL] [Abstract][Full Text] [Related]
2. The increasing prevalence of Parkinson's disease in Estonia.
Kadastik-Eerme L; Taba N; Asser T; Taba P
Acta Neurol Scand; 2018 Sep; 138(3):251-258. PubMed ID: 29707760
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Parkinson's disease in estonia.
Taba P; Asser T
Neuroepidemiology; 2003; 22(1):41-5. PubMed ID: 12566953
[TBL] [Abstract][Full Text] [Related]
4. Trends in Parkinson's disease related mortality in England and Wales, 1993-2006.
Mylne AQ; Griffiths C; Rooney C; Doyle P
Eur J Neurol; 2009 Sep; 16(9):1010-6. PubMed ID: 19538202
[TBL] [Abstract][Full Text] [Related]
5. The Modifying Effect of Age on Survival in Parkinson's Disease: A Population-Based Cohort Study.
Peretz C; Rozani V; Giladi N; El-Ad B; Tsamir J; Hemo B; Gurevich T
Neuroepidemiology; 2019; 53(1-2):13-19. PubMed ID: 31203291
[TBL] [Abstract][Full Text] [Related]
6. Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.
Hobson P; Meara J
BMJ Open; 2018 Feb; 8(2):e018969. PubMed ID: 29444783
[TBL] [Abstract][Full Text] [Related]
7. Mortality in patients with Parkinson's disease.
Wermuth L; Stenager EN; Stenager E; Boldsen J
Acta Neurol Scand; 1995 Jul; 92(1):55-8. PubMed ID: 7572061
[TBL] [Abstract][Full Text] [Related]
8. Standardized mortality ratio and seasonal fluctuations of mortality in Parkinson's disease.
Hristova DR
Folia Med (Plovdiv); 2009; 51(2):40-5. PubMed ID: 19670539
[TBL] [Abstract][Full Text] [Related]
9. Increase in Parkinson's disease-related mortality among males in Northern Italy.
Fedeli U; Schievano E
Parkinsonism Relat Disord; 2017 Jul; 40():47-50. PubMed ID: 28416129
[TBL] [Abstract][Full Text] [Related]
10. Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai.
Zhang Y; Wang C; Wang Y; Xiao Q; Liu J; Ma J; Zhou H; Pan J; Tan Y; Chen S; Xu G; Wang G
Parkinsonism Relat Disord; 2018 Oct; 55():75-80. PubMed ID: 29802079
[TBL] [Abstract][Full Text] [Related]
11. Incidence and mortality of Parkinson's disease in older Canadians.
Allyson Jones C; Wayne Martin WR; Wieler M; King-Jesso P; Voaklander DC
Parkinsonism Relat Disord; 2012 May; 18(4):327-31. PubMed ID: 22197034
[TBL] [Abstract][Full Text] [Related]
12. Mortality and cancer incidence in patients with Parkinson's disease.
Minami Y; Yamamoto R; Nishikouri M; Fukao A; Hisamichi S
J Neurol; 2000 Jun; 247(6):429-34. PubMed ID: 10929271
[TBL] [Abstract][Full Text] [Related]
13. Mortality and cause of death in South Korean patients with Parkinson's disease: a longitudinal follow-up study using a national sample cohort.
Choi HG; Lim JS; Lee YK; Sim S; Kim M
BMJ Open; 2019 Sep; 9(9):e029776. PubMed ID: 31530603
[TBL] [Abstract][Full Text] [Related]
14. Under-reporting of Parkinson's disease on death certificates: a population-based study (NEDICES).
Benito-León J; Louis ED; Villarejo-Galende A; Romero JP; Bermejo-Pareja F
J Neurol Sci; 2014 Dec; 347(1-2):188-92. PubMed ID: 25292414
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease patients first treated at age 75 years or older: a comparative study.
Peretz C; Chillag-Talmor O; Linn S; Gurevich T; El-Ad B; Silverman B; Friedman N; Giladi N
Parkinsonism Relat Disord; 2014 Jan; 20(1):69-74. PubMed ID: 24183677
[TBL] [Abstract][Full Text] [Related]
16. Causes of death in a community-based study of Parkinson's disease.
Beyer MK; Herlofson K; Arsland D; Larsen JP
Acta Neurol Scand; 2001 Jan; 103(1):7-11. PubMed ID: 11153892
[TBL] [Abstract][Full Text] [Related]
17. The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort.
Foltynie T; Matthews FE; Ishihara L; Brayne C;
BMC Neurol; 2006 Aug; 6():29. PubMed ID: 16925826
[TBL] [Abstract][Full Text] [Related]
18. Traumatic spinal cord injury in two European countries: why the differences?
Sabre L; Hagen EM; Rekand T; Asser T; Kõrv J
Eur J Neurol; 2013 Feb; 20(2):293-9. PubMed ID: 22891855
[TBL] [Abstract][Full Text] [Related]
19. Mortality from Parkinson's disease in China: Findings from a five-year follow up study in Shanghai.
Wang G; Li XJ; Hu YS; Cheng Q; Wang CF; Xiao Q; Liu J; Ma JF; Zhou HY; Pan J; Tan YY; Wang Y; Chen SD
Can J Neurol Sci; 2015 Jul; 42(4):242-7. PubMed ID: 26153040
[TBL] [Abstract][Full Text] [Related]
20. Mortality in a population-based cohort of patients treated with antiparkinsonian drugs.
Raschetti R; Spila-Alegiani S; Vanacore N; Ancona C; Meco G
Acta Neurol Scand; 1998 Jan; 97(1):20-6. PubMed ID: 9482674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
